The Treatment and Natural History of Acromegaly
NCT00001981 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 117
Last updated 2020-11-27
Summary
The purpose of this study is to investigate the treatment and natural history of acromegaly. We have a longstanding interest in acromegaly treatment, and a cohort that has been followed for 30 years, or more in some cases. We will continue to follow patients and recruit new patients for treatment and follow-up. Blood and pituitary tumor tissue (when available through clinical care) will be saved for future analyses related to acromegaly.
Conditions
- Acromegaly
- Pituitary Neoplasm
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
lead NIH
Principal Investigators
-
Phillip Gorden, M.D. · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1991-10-02
- Primary Completion
- 2020-11-20
- Completion
- 2020-11-20
Countries
- United States
Study Locations
More Related Trials
-
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
NCT01568359 ·Status: COMPLETED
-
Brain-gut Interaction in Irradiated Patients With Acromegaly
NCT02005978 ·Status: UNKNOWN
-
Diet in the Management of Acromegaly
NCT05401084 ·Status: RECRUITING ·Phase: NA
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly
NCT00225979 ·Status: COMPLETED ·Phase: PHASE3
-
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
NCT00921609 ·Status: COMPLETED
-
Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly
NCT02115906 ·Status: UNKNOWN
-
Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment
NCT01302652 ·Status: COMPLETED
-
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
NCT01995734 ·Status: APPROVED_FOR_MARKETING
-
Acromegaly Treatment Quality of Life Study
NCT01732406 ·Status: COMPLETED
-
Prospective Study on Changes in Acromegaly
NCT01612624 ·Status: UNKNOWN
-
Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
NCT00005100 ·Status: UNKNOWN
-
An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly
NCT00171730 ·Status: COMPLETED ·Phase: PHASE2
-
Acromegaly: Patient And Physician Perspectives
NCT03613623 ·Status: COMPLETED
-
Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly.
NCT02092129 ·Status: UNKNOWN
-
Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly
NCT01295060 ·Status: TERMINATED ·Phase: PHASE3
-
Cardiovascular Outcome After Surgery or Somatostatin Analogues
NCT00615004 ·Status: COMPLETED
-
Seoul National University Pituitary Disease Cohort Study
NCT03474601 ·Status: UNKNOWN
-
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
NCT00376064 ·Status: COMPLETED ·Phase: PHASE4
-
Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance
NCT00663000 ·Status: COMPLETED
-
Acromegaly Resistant to Conventional Dose of First Generation Somatostatin Ligands
NCT06607666 ·Status: COMPLETED
-
Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
NCT00552851 ·Status: UNKNOWN ·Phase: PHASE4
-
Description of Sign-and-symptom Associations at Acromegaly Diagnosis.
NCT02012127 ·Status: COMPLETED
-
Acromegaly Combination Treatment Study
NCT01538966 ·Status: TERMINATED ·Phase: NA
-
Acute Application of Pegvisomant and Octreotide in Acromegaly
NCT00595140 ·Status: COMPLETED ·Phase: PHASE4